Neuropacs Announces the Publication of a New Study Comparing the First-of-Its-Kind FDA De Novo–Classified Imaging Biomarker for Parkinson’s Disease With CSF Alpha-Synuclein Seed Amplification Assay (Business wire)
UF startup Neuropacs announced new research highlighting its AI-powered Parkinson’s diagnostic technology, which recently received FDA clearance for clinical use.
Rise Therapeutics Completes Enrollment in Four-Week Dose Expansion Cohort for the R-2487 Rheumatoid Arthritis Clinical Trial (PR Newswire)
UF startup Rise Therapeutics has completed enrollment in a Phase 1b clinical trial evaluating its oral immunotherapy candidate for patients with active rheumatoid arthritis.
UF Graduate Student Studying Turtle Movement Patterns To Decrease Boat Strikes (UF News)
A UF researcher is using satellite tracking to identify sea turtle collision hotspots and support efforts to reduce boat-related injuries in Florida waters.
Eight Decades After WWII Recognition, UF Engineers Still Power Defense Research (UF News)
The University of Florida played a key role in developing the WWII radio proximity fuze, while continuing to advance national security research and workforce development through UF FLARE facilities in Gainesville and at Eglin Air Force Base.
New Case Study Examines How a Supercomputer Became a University-Wide AI Strategy (UF News)
A new UF case study explores how the university’s HiPerGator AI initiative transformed teaching, research and workforce development through a campuswide expansion of AI education and infrastructure.
Tech Tuesday: University of Florida Lab Produce Tracers for Biomedical Imaging Modality (WCJB TV20)
In this week’s Tech Tuesday, UF Innovate highlights University of Florida research using magnetic particle imaging to improve how drug delivery is tracked and measured.
Old Lessons, New Outbreak: Experts Speak on the Bundibugyo Ebola Outbreak (UF EPI)
University of Florida researchers are analyzing the current Bundibugyo Ebola outbreak to better understand the virus’s behavior, transmission and public health risks.
Pheronym Awarded $378,000 NSF Phase IIB Supplemental Funding To Accelerate Commercialization and Scale Manufacturing (EIN Presswire)
UF Innovate | Accelerate alum Pheronym, an ag-biotech pest control company, announced it has been awarded $378,000 in National Science Foundation (NSF) SBIR Phase IIB supplemental funding.
Strawberry Producers Nationwide Rely on UF Plant Pathologists for Fast, Accurate, Disease Diagnoses; Fusarium Wilt Is Latest (UF/IFAS)
UF researchers are investigating the spread of Fusarium wilt, a difficult-to-control strawberry disease threatening growers along the East Coast.
A $3.5 Million Grant Will Help UF Researchers Identify Viruses, Limit Infectious Disease Spread (UF Health)
UF researchers received a $3.5 million grant to develop new diagnostic tools for detecting and monitoring dengue, yellow fever and other mosquito- and tick-borne diseases in Florida.